Related Experiment Video
Updated: Jun 8, 2025

06:50
A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
Published on: June 10, 2020
1.8K
Antisecretory Factor 16 (AF16): A Promising Avenue for the Treatment of Traumatic Brain Injury-An In Vitro Model
Nicola Vahrmeijer1, Jurgen Kriel2, Bradley M Harrington3
1Department of Physiological Sciences, Stellenbosch University, Merriman Avenue, Mike de Vries Building, Stellenbosch, 7600, South Africa.
Journal of Molecular Neuroscience : MN
|November 6, 2024
Summary
Antisecretory factor (AF16) shows promise for treating traumatic brain injury (TBI). This study found AF16 enhances autophagy and regulates mitochondria, offering neuronal protection post-injury.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Traumatic brain injury (TBI) results from external head trauma, causing brain dysfunction.
- Key TBI hallmarks include inflammation, increased intracranial pressure, and fluid buildup.
- Antisecretory factor (AF16) is explored for TBI therapy due to its anti-secretory and anti-inflammatory properties.
Purpose of the Study:
- To investigate the therapeutic potential of AF16 in an in vitro neuronal injury model.
- To examine AF16's effects on autophagy and mitochondrial dynamics post-injury.
- To determine the cellular localization and protective mechanisms of AF16.
Main Methods:
- N2Awt cells were treated with AF16 and subjected to scratch injury.
- Confocal microscopy, CLEM, flow cytometry, and western blotting were employed for analysis.
- Fluorescently labeled AF16 was used to track its cellular localization.
Main Results:
- AF16 treatment enhanced autophagy activity in injured neurons.
- AF16 regulated mitochondrial dynamics, crucial for cellular health.
- Neuronal protection was observed as early as 6 hours post-injury.
- AF16 localized to lysosomes and autophagic compartments.
Conclusions:
- AF16 demonstrates potential as a therapeutic agent for TBI.
- Regulation of autophagy and mitochondrial dynamics are key mechanisms of AF16's neuroprotection.
- AF16 may offer a novel treatment strategy for traumatic brain injury.

